{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:54:00Z","timestamp":1792688040624,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["C523400"],"award-info":[{"award-number":["C523400"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["C523100"],"award-info":[{"award-number":["C523100"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1008663"],"award-info":[{"award-number":["NRF-2021R1A2C1008663"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009847","name":"CHA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013587","name":"Alaska State Council on the Arts","doi-asserted-by":"publisher","award":["OC108"],"award-info":[{"award-number":["OC108"]}],"id":[{"id":"10.13039\/100013587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117528","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:48:06Z","timestamp":1762328886000},"page":"117528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Piperidinesulfonyl derivatives, novel CYP4A inhibitors, ameliorate hepatic lipotoxicity in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"243","author":[{"given":"Minji","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hyeon","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin-hyoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Doo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Rak","family":"Keum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Chul","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun-Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117528_b0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117528_b0010","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.bcp.2025.117528_b0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2025.117528_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction associated steatotic liver disease (MASLD): beyond insulin resistance","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117528_b0025","doi-asserted-by":"crossref","DOI":"10.4291\/wjgp.v15.i2.92791","article-title":"Metabolic dysfunction-associated steatotic liver disease heterogeneity: need of subtyping","volume":"15","author":"Habib","year":"2024","journal-title":"World J. Gastrointest. Pathophysiol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117528_b0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db18-0670","article-title":"Perilipin 5 deletion in hepatocytes remodels lipid metabolism and causes hepatic insulin resistance in mice","volume":"68","author":"Keenan","year":"2019","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2025.117528_b0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2025.117528_b0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1152\/physiol.00037.2018","article-title":"Impact of lipotoxicity on tissue \u201ccross talk\u201d and metabolic regulation","volume":"34","author":"Montgomery","year":"2019","journal-title":"Physiology"},{"issue":"6","key":"10.1016\/j.bcp.2025.117528_b0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/1871530322666211220110810","article-title":"Hepatic lipid metabolism disorder and atherosclerosis, endocrine","volume":"22","author":"Zhang","year":"2022","journal-title":"Metab. Immune Disord.-Drug Targets (Formerly Current Drug Targets-Immune Endocrine & Metabolic Disorders)"},{"issue":"6","key":"10.1016\/j.bcp.2025.117528_b0050","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s00125-016-3952-1","article-title":"Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions","volume":"59","author":"Cusi","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2025.117528_b0055","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: a focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117528_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117528_b0070","first-page":"60","article-title":"Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, touchREVIEWS","volume":"19","author":"Karim","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2025.117528_b0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.phrs.2018.09.025","article-title":"Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"137","author":"Bifari","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117528_b0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bcp.2025.117528_b0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.gastro.2014.06.039","article-title":"Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice","volume":"147","author":"Park","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.bcp.2025.117528_b0095","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.117528_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13036-019-0198-8","article-title":"Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model","volume":"13","author":"Ryu","year":"2019","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.bcp.2025.117528_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111798","article-title":"MEHP\/ethanol co-exposure favors the death of steatotic hepatocytes, possibly through CYP4A and ADH involvement","volume":"146","author":"T\u00eate","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2025.117528_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2022.11.001","article-title":"20-Hydroxytetraenoic acid induces hepatic fibrosis via the TGF-\u03b21\/Smad3 signaling pathway","volume":"373","author":"Li","year":"2023","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0120","first-page":"1121","article-title":"CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation","volume":"45","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117528_b0125","article-title":"The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): an RNA sequence database analysis and review","volume":"116241","author":"Leahy","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117528_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1497297","article-title":"The CYP4\/20-HETE\/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease","volume":"15","author":"Hardwick","year":"2025","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117528_b0135","doi-asserted-by":"crossref","first-page":"e1816","DOI":"10.1002\/ctm2.1816","article-title":"Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease","volume":"14","author":"Lee","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0140","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","article-title":"Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids","volume":"71","author":"Mun","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/mnfr.201500490","article-title":"Punicalagin attenuates palmitate\u2010induced lipotoxicity in HepG2 cells by activating the Keap1\u2010Nrf2 antioxidant defense system","volume":"60","author":"Yan","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0150","first-page":"1121","article-title":"CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS\u2011induced lipid peroxidation and inflammation","volume":"45","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.freeradbiomed.2005.04.001","article-title":"Nitration of \u03b3-tocopherol prevents its oxidative metabolism by HepG2 cells","volume":"39","author":"Wu","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"32","key":"10.1016\/j.bcp.2025.117528_b0160","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1074\/jbc.M116.732297","article-title":"20-hydroxyeicosatetraenoic acid (HETE)-dependent hypertension in human cytochrome P450 (CYP) 4A11 transgenic mice","volume":"291","author":"Savas","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bcp.2025.117528_b0165","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117528_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx253","article-title":"Asking the right questions with animal models: methionine- and choline-deficient model in predicting adverse drug reactions in human NASH","volume":"161","author":"Li","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117528_b0175","first-page":"4750","article-title":"An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function","volume":"8","author":"Lee","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0180","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117528_b0185","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1038\/emm.2016.157","article-title":"Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes","volume":"49","author":"Ly","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2025.117528_b0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2025.117528_b0195","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.molmet.2014.05.004","article-title":"ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload","volume":"3","author":"Egnatchik","year":"2014","journal-title":"Mol. Metab."},{"issue":"10","key":"10.1016\/j.bcp.2025.117528_b0205","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.117528_b0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0215","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117528_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9010009","article-title":"Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"9","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117528_b0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0230","doi-asserted-by":"crossref","first-page":"R934","DOI":"10.1152\/ajpregu.00125.2018","article-title":"High-fat diet-induced obesity and insulin resistance in CYP4a14(-\/-) mice is mediated by 20-HETE","volume":"315","author":"Gilani","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2025.117528_b0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function","volume":"192","author":"Rocic","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.117528_b0240","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein\u2013coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117528_b0245","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:00:54Z","timestamp":1775797254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0006295225007932"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117528","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piperidinesulfonyl derivatives, novel CYP4A inhibitors, ameliorate hepatic lipotoxicity in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117528"}}